Delstrigo

List of products in the National Drug Code with proprietary name delstrigo. This combination product is used by itself to help control HIV infection. It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. This product is a combination of 3 different drugs: doravirine, lamivudine, and tenofovir. Doravirine belongs to a class of drugs known as non-nucleoside reverse transcriptase inhibitors (NNRTIs). Lamivudine is called a nucleoside reverse transcriptase inhibitor and tenofovir is called a nucleotide reverse transcriptase inhibitor. Lamivudine and tenofovir are often called NRTIs. Doravirine/lamivudine/tenofovir is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, do all of the following: (1) continue to take all HIV medications exactly as prescribed by your doctor, (2) always use an effective barrier method (latex or polyurethane condoms/dental dams) during all sexual activity, and (3) do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
0006-5007Delstrigo Doravirine, Lamivudine, And Tenofovir Disoproxil FumarateTablet, Film CoatedOralMerck Sharp & Dohme LlcHuman Prescription Drug